Compare Bristol-Myers Squibb (BRM) vs. Competitors

20 Followers

Comparison Results

BRM

Bristol-Myers Squibb

€57.74

€111.22B

13.47

35.81%

8 Buy

12 Hold

1 Sell

Moderate Buy

Amgen

$442.24

$217.90B

24.85

35.52%

9 Buy

16 Hold

2 Sell

Moderate Buy

Eli Lilly & Co

$1233.66

$1.08T

38.24

39.40%

20 Buy

2 Hold

1 Sell

Strong Buy

Merck & Company

$156.45

$356.01B

114.52

61.21%

14 Buy

6 Hold

0 Sell

Moderate Buy

Novartis

$159.98

$256.80B

21.30

7.66%

2 Buy

3 Hold

1 Sell

Hold

AbbVie

$265.79

$464.43B

74.04

11.10%

19 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

BRM vs ABBV

xxxxxxxxxxxxx

Performance Comparison

DE:BRM

Bristol-Myers Squibb

54.08

17.03

45.96%

AMGN

Amgen

403.04

116.86

40.83%

LLY

Eli Lilly & Co

1,142.85

303.10

36.09%

MRK

Merck & Company

144.30

58.03

67.27%

NVS

Novartis

141.00

11.29

8.70%

ABBV

AbbVie

262.82

39.56

17.72%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >